Transferriini test: Miks põletik seda vähendab

Kategooriad
Artiklid
Raua uuringud Laboritulemuste tõlgendus 2026. aasta uuendus Patsientidele arusaadav

Madal transferriini tulemus võib peegeldada maksa reaktsiooni põletikule, mitte rauavarude vähenemist. Seerumi raua, ferriini, CRP ja transferriini koos lugemine hoiab ära levinud vead.

📖 ~11 minutit 📅
📝 Avaldatud: 🩺 Meditsiiniliselt üle vaadatud: ✅ Tõenduspõhine
⚡ Kiire kokkuvõte v1.0 —
  1. Negatiivne akuutfaasi valk: Transferriini tase langeb tavaliselt infektsiooni, autoimmuunhaiguste aktiivsuse, operatsiooni ja muude põletikuliste seisundite korral, isegi kui organismi rauavarud on piisavad.
  2. Tüüpiline täiskasvanu vahemik: Enamik laboreid kasutab transferriini võrdlusvahemikku umbes 200-360 mg/dl (2,0-3,6 g/l), kuid kohalikud analüüsi vahemikud on prioriteetsed.
  3. TSAT arvutus: Transferriini küllastus võrdub seerumi rauasisalduse jagamisel TIBC-ga ja korrutamisel 100-ga; madal TIBC võib muuta küllastuse vähem ebanormaalseks kui oodati.
  4. Ferritiini hoiatus: Ferriini tase tõuseb põletiku korral, seega ferriini tase alla 30 ng/ml tugevalt toetab rauavaegust, samas kui väärtus 100 ng/ml ei välista seda usaldusväärselt, kui CRP on kõrgenenud.
  5. Kasulik kaasnev test: Lahustuv transferriini retseptor on tavaliselt põletiku mõjust vähem mõjutatud kui ferriin või transferriin ja võib aidata segatüüpi aneemiat selgitada.
  6. Uusanalüüsi ajastus: Mitte-kriitiliste kõrvalekallete korral annab raua uuringute kordamine umbes 2–4 nädalat pärast lühiajalise haiguse möödumist sageli esinduslikuma lähtetaseme.
  7. Ärge ravige ennast pimedalt: Raualisaid võivad olla kasulikud tõestatud puuduse korral, kuid võivad olla sobimatud rauakülluse, aktiivse maksahaiguse või peamiselt põletikust põhjustatud aneemia korral.

Miks transferriini test langeb põletiku ajal?

Põletik alandab transferriini, kuna transferriin on negatiivne akuutfaasi valk. Tsütokiinid, eriti interleukiin-6, annavad maksale signaali vähendada transferriini tootmist, samal ajal kui hepitsidiin piirab raua vabanemist plasmasse; see võib põhjustada madalat transferriini ja madalat seerumi rauda, ilma et see tõestaks rauavarude ammendumist.

Transferrin test illustration showing liver protein production and iron transport proteins
Joonis 1: Maksast pärinev transferriin langeb, kuna põletikuline signaalimine suunab raua käitlemise ümber.

Lühiversioon on see, et keha muudab immuunaktiveerimise ajal ajutiselt raua vähem kättesaadavaks. Hepcidin vähendab ferriportiin-vahendatud raua väljavoolu enterotsüütidest ja makrofaagidest, nii et seerumi raud langeb sageli 24–48 tunni jooksul; maks võib samaaegselt vähendada transferriini sünteesi. See muster on peremehe kaitsereaktsioon, mitte otsene mõõtmine toidulisandi raua tarbimisest.

Oma kliinilises praktikas võib bakteriaalse kopsupõletiku järgselt inimesel, kelle CRP on 68 mg/L, olla seerumi raud 22 µg/dL ja transferriin 165 mg/dL, kuid ferriini 240 ng/mL. Selle üksiku mustri nimetamine “rauakülluseks” või rauavaeguse kindlaks väljajätmiseks oleksid mõlemad vead. Rauauuringud juhendavad selgitab alusmõisteid üksikasjalikumalt.

Kantesti on AI vereanalüüsi analüsaator mis loeb transferriini koos CRP, ferriini, täisvereloendi indeksite, maksa markerite ja varasemate tulemustega, selle asemel et pidada ühte madalat väärtust diagnoosiks. Dr. Thomas Kleini praktiline reegel on lihtne: palaviku, ägeda faasi või taastumise ajal saadud transferriini tulemus tuleks enne raviotsuse tegemist märgistada kui kontekstipõhine.

Akuutfaasi suund on oluline

CRP, ferriin, fibrinogeen ja haptoglobiin tõusevad üldiselt positiivsete akuutfaasi valkudena, samas kui transferriin ja albumiin võivad langeda. CRP üle 10 mg/L muudab üksiku ferriini väärtuse tõlgendamise oluliselt raskemaks, kuigi ükski universaalne CRP künnis ei saa iga patsiendi tulemust parandada.

Millised on transferriini ja TIBC normaalsed vahemikud?

Täiskasvanute transferriini tavaline vahemik on umbes 200–360 mg/dL ja TIBC vahemik on umbes 250–450 µg/dL. Need vahemikud erinevad laborimeetodi, soo, raseduse staatuse ja kohalike aruandlusühikute järgi, seega tuleks kasutada teie enda tulemuse kõrval olevat vahemikku.

Transferrin test laboratory assay materials arranged for measuring iron-binding capacity
Joonis 2: Laboratoorsed meetodid mõõdavad transferriini otseselt või hindavad selle rauaga seonduvat võimet.

Transferriini mõõdetakse tavaliselt otseselt mg/dL või g/L, samas kui kogu raua seonduv võime ehk TIBC, hindab, kui palju rauda saadaolev transferriin suudab siduda. Paljud laborid tuletavad TIBC transferriinist, selle asemel et seda eraldi mõõta; ligikaudne teisendus on TIBC µg/dL võrdub transferriiniga mg/dL korrutatud 1,25-ga. See seos on kasulik orienteerumiseks, mitte labori enda arvutuse ületamiseks.

Transferriini küllastus, lühendatult TSAT, arvutatakse seerumi raua jagamisel TIBC-ga korrutatud 100-ga. TSAT lähedal 20-45% on paljudes täiskasvanute laborites tüüpiline; väärtused alla 20% viitavad ringleva raua piirangule, kuid need ei erista iseenesest absoluutset rauavaegust põletikust tingitud raua sekvestreerimisest. Madal transferriini küllastus käsitleb seda eristust.

Mõned Euroopa laborid annavad transferriini kohta aru g/L, kus 2,0–3,6 g/L vastab laias laastus 200–360 mg/dL. Tulemus võib pärast viirusnakkust jääda veidi alla normvahemiku ja korduvatel uuringutel normaliseeruda, samas kui püsivad väärtused alla 150 mg/dL väärivad maksa sünteesiprobleemide, valgukao, olulise põletiku või alatoitumise sihipärast otsimist.

Tavaline täiskasvanu transferriin 200-360 mg/dL Sageli kooskõlas tüüpilise maksa sünteesi ja raua transpordivõimega.
Kõrge transferriin >360 mg/dL Sageli esinev rauavaeguse, raseduse, östrogeeni ekspositsiooni või rauakao järgse taastumise korral.
Low transferrin 150-199 mg/dL May reflect inflammation, liver disease, protein loss, or reduced nutritional intake.
Markedly low transferrin <150 mg/dL Requires clinical context and assessment for serious inflammatory, hepatic, or protein-losing conditions.

Kuidas raua uuringuid tulemuste kogumina tõlgendada?

Iron studies are safest when serum iron, transferrin or TIBC, TSAT, ferritin, and an inflammatory marker are interpreted together. Serum iron alone changes markedly across the day and may fall by more than 30% between samples in the same person.

Transferrin test pattern displayed through laboratory samples and cellular iron transport model
Joonis 3: Serum iron, TIBC, ferritin, and CRP answer different clinical questions.

Classic uncomplicated iron deficiency usually produces low serum iron, high transferrin or TIBC, TSAT below 20%, and ferritin below 30 ng/mL. The high TIBC occurs because the liver increases transferrin production when iron availability is low. A rising red-cell distribution width can appear before hemoglobin falls; see our guide to RDW changes after iron therapy for the time course.

Anemia of inflammation more often produces low serum iron, low or normal transferrin, low TSAT, and ferritin that is normal or high. Weiss and Goodnough described this as iron-restricted erythropoiesis caused by impaired iron availability rather than necessarily absent stored iron (Weiss & Goodnough, 2005). The two states commonly coexist, particularly in inflammatory bowel disease, rheumatoid arthritis, chronic kidney disease, and cancer.

One less obvious trap is arithmetic: if serum iron is 30 µg/dL and TIBC is suppressed to 180 µg/dL, TSAT is 17%. If TIBC were 360 µg/dL, the same serum iron would yield 8%. The lower denominator can conceal how little iron is circulating, which is why madal seerumi raud needs context rather than a reflex prescription.

A practical mixed-pattern clue

Ferritin between 30 and 100 ng/mL with TSAT below 20% and CRP above 10 mg/L is often a gray zone, not reassurance. In that setting, clinicians may use soluble transferrin receptor, reticulocyte hemoglobin content, trend data, or a therapeutic plan tailored to the underlying illness.

Miks ferriini tase võib olla normaalne, kui raud on madal

Ferritin is both an iron-storage protein and a positive acute-phase reactant, so inflammation can raise it independently of stored iron. A ferritin below 30 ng/mL strongly supports iron deficiency in most adults, but a higher value cannot reliably exclude deficiency when CRP or ESR is raised.

Transferrin test context with ferritin protein storage and inflammatory signaling illustration
Joonis 4: Inflammation can raise ferritin while lowering transferrin and circulating iron.

The World Health Organization’s 2020 ferritin guideline advises measuring inflammation markers alongside ferritin where infection or inflammation is prevalent. In adults with inflammation, WHO suggests ferritin below 70 µg/L may indicate iron deficiency; that is a population-informed threshold, not a substitute for an individual clinical assessment (WHO, 2020).

I often see patients alarmed by ferritin of 180 ng/mL after an inflammatory flare, assuming their iron stores must be abundant. Sometimes they are. Yet ferritin can rise after strenuous exercise, liver cell injury, metabolic disease, alcohol exposure, and immune activity, so the number is not a standalone inventory count. Ferritin and CRP is a helpful companion discussion.

Kantesti on AI vereanalüüsi tulemuste tõlgendamise platvorm that flags the discordant combination of low transferrin, low TSAT, and elevated CRP as possible inflammation-associated iron restriction. Our 2M+ user dataset is not a replacement for diagnostic research, but it repeatedly reinforces a clinician’s old lesson: ferritin behaves differently when the patient is actively unwell.

Ferritin values that need a different conversation

Ferritin above 1,000 ng/mL warrants timely medical review because severe inflammation, significant liver injury, iron overload syndromes, and several other conditions can produce that range. The urgency depends on symptoms, liver enzymes, transferrin saturation, and the speed of change rather than the ferritin number alone.

Millised testid selgitavad rauavaegust põletiku ajal?

Soluble transferrin receptor and reticulocyte hemoglobin content can help identify iron-restricted red-cell production when ferritin and transferrin disagree. Soluble transferrin receptor generally rises with cellular iron need and is less distorted by acute inflammation than ferritin.

Transferrin test follow-up using soluble receptor assay and reticulocyte cell analysis
Joonis 5: Additional red-cell iron markers can clarify discordant inflammatory iron studies.

Soluble transferrin receptor, or sTfR, reflects transferrin receptor expression from erythroid precursors. It usually rises in absolute iron deficiency and is often normal in pure anemia of inflammation; however, assay reference intervals are not standardized, and hemolysis or high erythropoietic activity can elevate it. This is one of those areas where the exact laboratory method matters more than online cutoffs.

Reticulocyte hemoglobin content, reported as CHr or Ret-He depending on the analyzer, reflects iron available to newly produced red cells over roughly the prior 2-4 days. Values below about 28-30 pg can support iron-restricted erythropoiesis, although local thresholds and kidney-disease protocols differ. Soluble transferrin receptor testing explains where it fits.

Bone marrow iron staining remains a historical reference method but is rarely necessary solely to resolve a routine outpatient iron panel. Dr. Thomas Klein generally favors repeating samples after recovery, reviewing bleeding and dietary history, and using sTfR or reticulocyte measures when the answer will genuinely alter treatment; extra tests without a decision attached tend to create noise.

The sTfR-ferritin index

Some specialists calculate the sTfR/log ferritin index, which can improve discrimination in inflammatory settings. Cutoffs vary substantially by assay, often from roughly 1.0 to 3.2, so a result should be interpreted with the laboratory’s validated method rather than a borrowed internet threshold.

Millal tuleks transferriini testi korrata?

A transferrin test is best repeated after a short-lived infection, fever, or major inflammatory event has settled, usually after 2-4 weeks if the situation is not urgent. Morning collection and consistent pre-test conditions reduce avoidable variation in serum iron and TSAT.

Transferrin test preparation scene with morning laboratory sample handling and calendar markers
Joonis 6: Consistent timing improves comparison of iron studies across separate blood draws.

Serum iron has diurnal variation and can be lower later in the day, while recent oral iron can transiently raise it. Many clinicians request a morning sample after an overnight fast of roughly 8-12 hours when they need a clean comparison, although fasting is not mandatory for every iron study. Follow the ordering clinician’s instructions rather than stopping prescribed medicines on your own.

A transferrin result taken 48 hours after a marathon, dental procedure, vaccine, or acute respiratory illness may reflect an acute-phase response rather than a durable iron pattern. Exercise can also alter CK, plasma volume, and ferritin; endurance athletes may find our runner iron testing guide kasulikuks.

Kantesti’s trend analysis compares dates, not simply reference flags, and can highlight a fall from 310 mg/dL to 180 mg/dL that coincides with CRP rising from 1 to 52 mg/L. That is clinically more informative than either isolated result. Review TIBC test preparation before arranging a planned repeat.

When not to wait for a repeat

Do not postpone medical review for repeat testing if severe breathlessness, chest pain, fainting, black stools, heavy ongoing bleeding, jaundice, or rapidly worsening weakness is present. Hemoglobin below 80 g/L (8 g/dL) is often clinically significant, but urgency depends on symptoms, rate of fall, pregnancy status, and cardiovascular disease.

Kuidas CRP, ESR ja hepdiin selgitavad madalat transferriini taset?

CRP and ESR do not measure iron stores, but they show whether inflammation may be distorting a transferrin test. CRP rises and falls over hours to days, whereas ESR can remain elevated for weeks because it is influenced by fibrinogen, anemia, age, and immunoglobulins.

Transferrin test inflammation pathway showing CRP, hepcidin, and liver response in a clinical model
Joonis 7: Inflammatory signals increase hepcidin and reduce circulating iron availability.

Interleukin-6 stimulates hepatic hepcidin production, and hepcidin binds ferroportin, causing reduced iron export from macrophages and intestinal cells. Ganz and Nemeth’s review describes this pathway as central to anemia of inflammation and iron-restricted erythropoiesis (Ganz & Nemeth, 2012). The result may be low serum iron within a day while transferrin falls as part of the same systemic response.

CRP below 5 mg/L is often considered within the reference range, though laboratories differ. A CRP of 40 mg/L does not identify the cause of inflammation, but it should make a clinician more cautious about diagnosing iron deficiency from ferritin or transferrin alone. Kõrge ESR-i põhjused explains why ESR is slower and less specific.

Kantesti AI interprets transferrin results by comparing the direction of CRP, ferritin, albumin, white-cell count, and recent trends. This is not a diagnosis engine for infection or autoimmune disease; it is a structured prompt to ask whether the iron panel was obtained during a biologically unstable moment.

Why hepcidin is not routinely measured

Hepcidin assays remain limited by availability, standardization, and turnaround time in ordinary practice. A hepcidin value can be informative in specialist research or unusual anemia cases, but serum ferritin, TSAT, CRP, kidney function, and blood-count indices remain the practical first-line tools.

Kuidas põletikust tingitud aneemia erineb rauavaegusest?

Absolute iron deficiency means total body iron is insufficient, while anemia of inflammation means iron is present but poorly available for red-cell production. Both can produce fatigue, low TSAT, and a falling hemoglobin, and they frequently occur together.

Transferrin test comparison of iron deficiency and inflammation-related iron restriction cellular patterns
Joonis 8: Iron depletion and inflammatory iron restriction share low circulating iron but differ in storage signals.

In uncomplicated iron deficiency, ferritin is usually low and transferrin often rises above 360 mg/dL as binding capacity increases. In anemia of inflammation, transferrin commonly falls below 200 mg/dL, ferritin is often above 100 ng/mL, and CRP may be elevated. Neither pattern is absolute; chronic kidney disease and liver disease are especially prone to overlap.

Hemoglobin and MCV can lag behind iron restriction. A person can have ferritin 18 ng/mL, TSAT 14%, and a normal hemoglobin of 132 g/L, particularly early in deficiency; conversely, inflammation can cause anemia with a normal MCV of 82-100 fL. What hemoglobin means helps put the CBC beside iron studies.

The reason we worry about low transferrin combined with low albumin is that together they suggest either a stronger inflammatory burden, impaired hepatic synthesis, or protein loss, whereas low transferrin alone after a cold is often transient. A clinician should review kidney function, urine protein, liver tests, nutrition, medicines, bleeding history, and the trajectory over at least two draws.

Treatment is not interchangeable

Oral iron often improves absolute deficiency, but it may have limited effect while inflammation keeps hepcidin high. In selected conditions, such as chronic kidney disease or active inflammatory bowel disease, clinicians may use intravenous iron or treat the inflammatory driver first; the approach depends on diagnosis, symptoms, hemoglobin, and safety considerations.

Miks madal transferriini tase võib moonutada transferriini küllastust?

Low transferrin can make transferrin saturation appear less low because TSAT uses TIBC as its denominator. A normal or mildly low TSAT does not always mean iron delivery is adequate when TIBC is suppressed by inflammation or liver dysfunction.

Transferrin test calculation concept using iron-binding capacity assay and proportional laboratory samples
Joonis 9: A reduced TIBC changes the denominator used to calculate transferrin saturation.

Consider serum iron of 36 µg/dL. With a TIBC of 360 µg/dL, TSAT is 10%; with a TIBC of 180 µg/dL, TSAT is 20%. The second result appears less concerning mathematically, but both samples contain the same low circulating iron. This is why clinicians should inspect the raw values, not only the percentage.

The opposite pitfall occurs in advanced liver injury or acute hepatocellular damage: transferrin production can fall and serum iron may rise from altered handling, producing an elevated TSAT. TSAT persistently above 45% merits evaluation for iron overload in the right context, but it should not be used to diagnose hereditary hemochromatosis during an acute liver event. Read our cirrhosis blood-test clues for wider hepatic context.

Kantesti on AI-põhine vereanalüüsi analüüsitööriist used across 127+ countries, so it normalizes units before calculating saturation and marks results that may be mathematically unstable because TIBC is unusually low. The output should support, not replace, the clinician who knows whether a patient has fever, hepatitis, nephrotic syndrome, or recent iron treatment.

Do not use TSAT as a hydration marker

Dehydration can concentrate several serum measurements but does not create a dependable iron-overload pattern. If albumin, hematocrit, urea, and sodium suggest reduced plasma volume, repeating the panel after normal hydration may be sensible before attaching meaning to a borderline TSAT.

Mis veel põhjustab madalat transferriini taset peale põletiku?

Low transferrin also occurs with reduced liver synthesis, protein loss through the kidneys or gut, inadequate protein-energy intake, and rarely congenital disorders. Inflammation is common, but it should never become a catch-all explanation without checking the rest of the panel.

Transferrin test clinical evaluation showing liver, kidney protein loss, and nutrition assessment objects
Joonis 10: Low transferrin may arise from inflammation, impaired synthesis, or protein loss.

The liver synthesizes transferrin, so low transferrin with elevated bilirubin, INR, AST, ALT, or low albumin may point toward hepatic disease rather than iron status. Severe liver dysfunction can reduce transferrin below 150 mg/dL. Liver panel results help determine whether that explanation is plausible.

Nephrotic-range urinary protein loss can remove transferrin along with albumin and other proteins. A urine albumin-creatinine ratio above 300 mg/g, or 30 mg/mmol, is severely increased albuminuria and calls for kidney-focused assessment; dipstick protein alone is not enough for a full answer. See our guide to uriinis oleva valgu kohta.

Poor intake, malabsorption, or severe catabolic illness can lower transferrin, although transferrin is too inflammation-sensitive to serve as a nutritional marker by itself. Congenital atransferrinemia is exceptionally rare and usually presents much earlier in life with severe anemia and paradoxical systemic iron loading. That unusual combination needs specialist hematology input.

Medication and hormone effects

Estrogen exposure and pregnancy can increase transferrin, while androgens may lower it modestly. These shifts are usually smaller than the effects of significant inflammation or liver disease, but they can explain a borderline result when the rest of the iron panel is stable.

Kuidas rasedus ja menstruaalverekaotus muudavad transferriini taset?

Pregnancy often raises transferrin and TIBC, while iron requirements increase most sharply in the second and third trimesters. Therefore, a low transferrin result in pregnancy deserves particular attention to inflammation, liver function, protein loss, and laboratory context.

Transferrin test pregnancy-related iron study scene with maternal laboratory sample and iron foods
Joonis 11: Pregnancy raises iron demand and usually increases transferrin binding capacity.

Plasma volume expands during pregnancy, and estrogen increases transferrin synthesis, so TIBC often rises above the non-pregnant range. Ferritin also normally trends downward as pregnancy progresses; a ferritin below 30 µg/L is commonly used to identify depleted stores in pregnancy, although local maternity guidelines may vary. Ferritin by trimester provides practical ranges.

Heavy menstrual bleeding is a common cause of absolute iron deficiency, especially when ferritin is below 30 ng/mL and transferrin is elevated rather than suppressed. Yet a person with autoimmune disease and heavy periods can have both blood-loss deficiency and inflammation; a “normal” ferritin of 75 ng/mL does not settle the question when CRP is 24 mg/L.

New low transferrin with high blood pressure, swelling, proteinuria, headache, right-upper abdominal pain, or abnormal liver tests during pregnancy needs prompt obstetric assessment. It is not a way to diagnose pre-eclampsia, but the wider protein and liver pattern can matter far more than the iron result alone.

Kuidas tõlgendatakse transferriini neerukao ja kroonilise haiguse korral?

Chronic kidney disease commonly causes functional iron deficiency because inflammation and reduced erythropoietin limit usable iron for red-cell production. In this setting, TSAT below 20% and ferritin below 100 ng/mL often support iron deficiency before dialysis, though treatment thresholds vary by guideline and clinical setting.

Transferrin test in chronic kidney disease showing renal function analysis and iron transport illustration
Joonis 12: Kidney disease can combine reduced erythropoiesis with inflammation-related iron restriction.

KDIGO guidance has historically used a trial-of-iron framework in many adults with CKD when TSAT is at or below 30% and ferritin is at or below 500 ng/mL, provided the clinical goal is to raise hemoglobin or reduce erythropoiesis-stimulating therapy. These are treatment considerations, not universal definitions of normal iron stores, and the 500 ng/mL ceiling is often misunderstood.

A patient with eGFR 28 mL/min/1.73 m², hemoglobin 96 g/L, TSAT 16%, ferritin 220 ng/mL, and CRP 12 mg/L may have functional deficiency despite non-low ferritin. Oral iron absorption can be reduced, and clinicians must also assess B12, folate, occult loss, erythropoietin use, and kidney trajectory. CKD staging offers useful background.

Kantesti AI can place transferrin in a longitudinal kidney-health context, but it cannot determine whether intravenous iron, erythropoiesis-stimulating therapy, or specialist referral is appropriate. That decision requires symptoms, blood pressure, infection status, medication review, and the full renal record.

Millal vajab madal transferriini tulemus kiiret läbivaatamist?

Low transferrin needs prompt medical review when it accompanies significant anemia, jaundice, swelling, heavy bleeding, black stools, unexplained weight loss, or evidence of kidney or liver dysfunction. The result itself is rarely an emergency, but the condition behind it occasionally is.

Transferrin test clinician review showing urgent laboratory pattern assessment in a calm consultation setting
Joonis 14: Urgency depends on the accompanying anemia, liver, kidney, and bleeding pattern.

Same-day assessment is sensible for chest pain, fainting, severe shortness of breath, confusion, black tarry stool, vomiting blood, or rapidly increasing swelling. Hemoglobin below 70 g/L (7 g/dL), bilirubin above 50 µmol/L with jaundice, or an unexpectedly high INR requires individual clinical judgment and may need urgent evaluation. Do not attempt to correct those patterns with over-the-counter iron alone.

For a stable, mildly low transferrin of 185 mg/dL with normal hemoglobin, normal liver tests, and CRP 18 mg/L during a documented respiratory infection, a repeat panel after recovery is often reasonable. If it persists for more than 6-8 weeks, clinicians commonly expand the review to liver panel, urine protein, nutritional history, inflammatory disease activity, and bleeding sources.

Our clinical content is reviewed with the support of the Meditsiininõukogu, and Kantesti’s interpretation logic is documented through our meditsiinilise valideerimise raamistik. As of September 5, 2026, the safest message remains unchanged: a low transferrin result is a clue about iron transport and systemic physiology, not a diagnosis by itself.

Korduma kippuvad küsimused

Kas põletik võib põhjustada madalat transferriini ilma rauapuuduseta?

Jah. Põletik võib vähendada transferriini isegi siis, kui rauavarud on piisavad, kuna transferriin on negatiivne akuutfaasi valk, mida toodab maks. CRP üle 10 mg/L-ga inimestel võib põletikust tingitud rauasemosteerimise tõttu olla madal transferriin, madal seerumi raua sisaldus ja ferritiin üle 100 ng/mL, mitte puhas rauavaegus. Rauavaegus võib siiski esineda, eriti kui TSAT on alla 20% või ferritiin on alla 30 ng/mL. Arst peaks tõlgendama kogu pilti ja põletiku põhjust.

Kas madal transferriin tähendab madalat rauasisaldust?

Madal transferriini tase ei tähenda automaatselt keha madalat rauasisaldust. Madal transferriini tase esineb sageli põletiku, maksahaiguse, neeruvalgukao ja ebapiisava valgudieedi korral, samas kui klassikaline rauavaegus tõstab transferriini tavaliselt üle umbes 360 mg/dL. Alla 50 µg/dL seerumi raud võib esineda nii rauavaeguse kui ka põletiku korral, seetõttu on vaja ferritiini, CRP, TIBC, TSAT ja vereanalüüsi. Transferriini tulemus alla 200 mg/dL tuleks tõlgendada koos labori referentsväärtuste ja kliinilise anamneesiga.

Kas madal transferriin võib muuta transferriini küllastatuse normaalseks?

Jah. Transferriini küllastus on seerumi raud jagatud TIBC-ga korrutatud 100-ga, nii et madal transferriinist põhjustatud madal TIBC tekitab väiksema nimetaja. Näiteks seerumi raud 36 µg/dL annab TSAT-i 10%, kui TIBC on 360 µg/dL, kuid 20%, kui TIBC on 180 µg/dL. See tähendab, et piiripealne TSAT võib alahinnata rauapiirangut, kui transferriin on allasurutud. Arstid peaksid kontrollima nii protsenti kui ka tooreid seerumi raua ja TIBC väärtusi.

Milline ferriinitase kinnitab rauavaegust põletiku ajal?

Ferriit tase alla 30 ng/mL või µg/L viitab enamikul täiskasvanutest tugevalt rauapuudusele, sealhulgas paljudel inimestel kerge põletikuga. WHO 2020. aasta suunis soovitab, et ferriit alla 70 µg/L võib viidata rauapuudusele täiskasvanutel koos põletiku tunnustega, kuid see piirväärtus ei ole absoluutne igale indiviidile. Ferriit võib tõusta koos CRP taseme tõusu, maksa kahjustuse ja ainevahetushaigustega, seetõttu nõuavad 30–100 ng/mL vahelised väärtused sageli TSAT, CRP ja mõnikord lahustuva transferriini retseptori testimist. Ferriit üle 100 ng/mL ei välista alati rauapuudust, kui esineb põletikuline aktiivsus.

Kui kaua pärast haigust peaksin kordama transferriini testi?

Vähemtähtsate mööduvate haiguste korral on sageli otstarbekas korrata transferriini testi umbes 2–4 nädalat pärast sümptomite ja palaviku taandumist, kui puuduvad kiireloomulised tunnused. CRP võib normaliseeruda mõne päevaga, kuid ESR, ferritiini, albumiini ja transferriini taseme normaliseerumine võib võtta kauem aega. Korduvaks analüüsiks kasutage sarnaseid tingimusi, ideaalis hommikust proovi ja võimalusel sama laborit. Ärge lükake edasi läbivaatust, kui hemoglobiinitase langeb, verejooks jätkub või maksa- ja neerude näitajad on ebanormaalsed.

Kas ma peaksin võtma rauapreparaate madala transferriini korral?

Madal transferriinitase iseenesest ei ole põhjus rauapreparaatide alustamiseks. Suukaudset rauda kaalutakse tavaliselt absoluutse rauavaeguse korral, nagu ferritiin alla 30 ng/mL, madal TSAT, sobivad sümptomid või selge kaotuse allikas; annus ja manustamissagedus tuleb individuaalselt määrata. Põletikuanemiat korral võib raud halvasti imenduda või olla kättesaamatu, kuna heptsidiini tase on kõrge, ja alusprobleemi ravimine võib olla olulisem. Raud võib olla kahjulik või eksitav rauakuhjumise häirete ja mõnede maksahaiguste korral, seega kinnitage probleemiga arsti poole.

Hangi AI-toega vereanalüüsi analüüs juba täna

Liitu enam kui 2 miljoni kasutajaga üle maailma, kes usaldavad Kantesti-d kohese ja täpse laborianalüüsi jaoks. Laadi üles oma vereanalüüsi tulemused ja saad põhjaliku tõlgenduse 15,000+ biomarkerite kohta sekunditega.

📚 Viidatud teaduspublikatsioonid

1

Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti vereanalüüsi tõlgendamise mootori automatiseeritud tehniline võrdlusuuring, mis põhineb eelregistreeritud rubriigil, 100 000 sünteetilise testjuhtumi peal. Kantesti AI Medical Research.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Kliinilise valideerimise raamistik v2.0 (meditsiinilise valideerimise leht). Kantesti AI Medical Research.

📖 Välised meditsiinilised viited

3

Maailma Terviseorganisatsioon (2020). WHO juhend ferritiini kontsentratsioonide kasutamiseks rauaseisundi hindamisel üksikisikutel ja populatsioonides. Maailma Terviseorganisatsioon.

4

Weiss G, Goodnough LT (2005). Kroonilise haiguse aneemia. New England Journal of Medicine.

5

Ganz T, Nemeth E (2012). Hepcidin and iron homeostasis. Biochimica et Biophysica Acta.

2+ kuudAnalüüsitud testid
127+Riigid
75+Keeled

⚕️ Meditsiiniline lahtiütlus

E-E-A-T usaldussignaalid

Kogemus

Arsti juhitud kliiniline ülevaade labori tõlgendamise töövoogudest.

📋

Ekspertiis

Laborimeditsiin keskendub sellele, kuidas biomarkerid käituvad kliinilises kontekstis.

👤

Autoriteetsus

Kirjutanud dr Thomas Klein, ülevaade: dr Sarah Mitchell ja prof dr Hans Weber.

🛡️

Usaldusväärsus

Tõenduspõhine tõlgendus selgete edasiste sammudega, et vähendada ärevust.

🏢 Kantesti OÜ Registreeritud Inglismaal ja Walesis · Ettevõtte nr. 17090423 London, Ühendkuningriik · kandesti.net
blank
Prof. Dr. Thomas Klein poolt

Dr. Thomas Klein on juhatuse poolt sertifitseeritud kliiniline hematoloog, kes töötab Kantesti AI-s meditsiinijuhina (Chief Medical Officer). Tal on üle 15 aasta kogemust laborimeditsiinis ning tugev huvi AI-toega vereanalüüsi tulemuste tõlgendamise vastu. Ta püüab siduda uue tehnoloogia igapäevase kliinilise praktikaga. Tema huvivaldkondade hulka kuuluvad biomarkerite analüüs, kliinilise otsustustoetuse alane teadustöö ning populatsioonipõhiste referentsvahemike optimeerimine. Meditsiinijuhina annab ta platvormi sisemisele võrdlusanalüüsile kliinilise sisendi ning tagab Kantesti haridusaruannete meditsiinilise kvaliteedi järelevalve.

Lisa kommentaar

Sinu e-postiaadressi ei avaldata. Nõutavad väljad on tähistatud *-ga